Group 4F: Metastatic Breast Cancer; Immunotherapy; Vaccines; Tumor Microenvironment

Poster #P1-01-17: PD-L1 Upregulation in Circulating Tumor Associated Cells Predicts for clinical outcomes in a phase I/II clinical trial using SVBR-1-GM vaccine with the check point inhibitor retifanlimab in Metastatic Breast Cancer Patients, an Interim Analysis

Poster #P3-09-16: SerpinE2 mediated cell competition during breast cancer metastasis to the liver